JPMorgan Chase & Co. Lowers Stake in UroGen Pharma Ltd. (NASDAQ:URGN)
JPMorgan Chase & Co. decreased its holdings in shares of UroGen Pharma Ltd. (NASDAQ:URGN – Free Report) by 69.0% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 21,114 shares of the company’s stock after selling 46,948 shares during the period. JPMorgan Chase & Co.’s holdings […]
JPMorgan Chase & Co. decreased its holdings in shares of UroGen Pharma Ltd. (NASDAQ:URGN – Free Report) by 69.0% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 21,114 shares of the company’s stock after selling 46,948 shares during the period. JPMorgan Chase & Co.’s holdings […]
